GLENMEDE TRUST CO NA
BankPosition in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 314949
PHILADELPHIA, PA
Position in VRTX
as of Mar 31, 2026
· filed May 26, 2026
Position Value
$2,504,195
+$83,707 QoQ
Shares Held
5,608
+5.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 28.31669044222539.ToString("F0")%
Shared 0.ToString("F0")%
None 71.6833095577746.ToString("F0")%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GLENMEDE TRUST CO NA holds $121,614,834 across 47 Biotechnology names. VRTX ranks #6 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
523,291 | $49,252,148 | |
| 2 | CPRX |
Catalyst Pharmaceuticals, Inc.
|
565,424 | $13,999,896 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
18,059 | $13,953,104 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
146,717 | $9,482,319 | |
| 5 | ACAD |
Acadia Pharmaceuticals Inc
|
405,892 | $9,035,155 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
5,608 | $2,504,195 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
7,819 | $1,478,181 | |
| 8 | AXSM |
Axsome Therapeutics, Inc.
|
6,716 | $1,135,138 |
All Filings in VRTX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,504,195 | 5,608 | Shares | Sole | 2026-05-26 | |
| 2025-12-31 | $2,420,488 | 5,339 | Shares | Sole | 2026-02-17 | |
| 2025-03-31 | $2,295,622 | 4,735 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,943,027 | 4,825 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,903,572 | 4,093 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $62,254,452 | 132,818 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $56,465,207 | 135,081 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $70,837,921 | 174,096 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $67,598,220 | 194,393 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $69,938,944 | 198,741 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $62,650,723 | 198,847 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $55,071,212 | 190,703 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $46,246,197 | 159,723 | Shares | Sole | 2022-11-16 | |
| 2022-06-30 | $44,402,213 | 157,572 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $42,009,644 | 160,975 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $3,062,761 | 13,947 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $2,773,814 | 15,292 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $2,580,661 | 12,799 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $1,397,643 | 6,504 | Shares | Sole | 2021-05-18 | |
| 2020-12-31 | $15,507,920 | 65,617 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $995,685 | 3,659 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $902,573 | 3,109 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $598,444 | 2,515 | Shares | Defined | 2020-05-20 | |
| No filing history on record for this holder in this stock. | ||||||